Bioatla Inc (BCAB)

04:07 AM

Will BioAtla Inc. see short term momentum2025 EndofYear Setup & Trade Opportunity Analysis - Newser

04:07 AM

06:47 AM

Exit strategy if you’re trapped in BioAtla Inc.Quarterly Trade Summary & Risk Managed Investment Signals - Newser

06:47 AM

05:26 AM

Can BioAtla Inc. rally from current levels2025 Support & Resistance & Capital Protection Trading Alerts - Newser

05:26 AM

04:46 AM

BioAtla downgraded to Market Perform from Outperform at Citizens JMP - MSN

04:46 AM

03:56 AM

Using data filters to optimize entry into BioAtla Inc.2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser

03:56 AM

03:14 AM

BioAtla’s Earnings Call: Positive Clinical Progress Amid Financial Challenges - MSN

03:14 AM

02:43 AM

JMP Securities Reiterates “Market Perform” Rating for BioAtla (NASDAQ:BCAB) - Defense World

02:43 AM

02:43 AM

BioAtla (NASDAQ:BCAB) Rating Lowered to Market Perform at Citizens Jmp - Defense World

02:43 AM

Aug 14, 2025

How sentiment analysis helps forecast BioAtla Inc.Weekly Trend Summary & AI Powered Market Trend Analysis - Newser

Aug 14, 2025

Aug 14, 2025

BioAtla's BCAB Downgraded to Market Perform by JMP Securities - AInvest

Aug 14, 2025

Aug 14, 2025

Combining price and volume data for BioAtla Inc.Portfolio Return Report & Weekly High Momentum Picks - Newser

Aug 14, 2025

Aug 14, 2025

HC Wainwright Predicts BioAtla’s Q3 Earnings (NASDAQ:BCAB) - Defense World

Aug 14, 2025

Aug 13, 2025

BioAtla’s SWOT analysis: oncology biotech’s stock faces cash crunch - Investing.com

Aug 13, 2025

Aug 13, 2025

BioAtla stock downgraded by Citizens JMP on cash concerns - Investing.com Canada

Aug 13, 2025

Aug 13, 2025

Has BioAtla Inc. formed a bullish divergence [2025 Institutional Moves]AI Based Buy and Sell Signals - Newser

Aug 13, 2025

Aug 13, 2025

Will BioAtla Inc. see short term momentum [2025 Market Trends]Accurate Intraday Trading Signals - Newser

Aug 13, 2025

Aug 12, 2025

Why BioAtla Inc. stock attracts strong analyst attentionDay Trading Plan with Entry Risk Management - Newser

Aug 12, 2025

Aug 12, 2025

What technical models suggest about BioAtla Inc.’s comebackFree Portfolio Diversification Stock Ideas - Newser

Aug 12, 2025

Aug 12, 2025

Analysts Apply Wyckoff Model to BioAtla Inc. StockBuy Low Sell High Stock Watch Strategy in Focus - 선데이타임즈

Aug 12, 2025

Aug 12, 2025

BioAtla, Inc. (NASDAQ:BCAB) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 12, 2025

Aug 12, 2025

What makes BioAtla Inc. stock price move sharplyWatchlist Generator for Smart Money Signals - Newser

Aug 12, 2025

Aug 10, 2025

BioAtla Inc. stock trend outlook and recovery pathFree Stable Entry High Return Opportunities - Newser

Aug 10, 2025

Aug 10, 2025

Buy Signal for BioAtla Inc. Stock Key Technical Indicators to WatchFree Conservative Entry for High Return Setup - Newser

Aug 10, 2025

Aug 10, 2025

What institutional flow reveals about BioAtla Inc.Automated AI Forecast with Trading Alerts - Newser

Aug 10, 2025

Aug 10, 2025

BioAtla Inc. Testing Reversal Zone on Weekly ChartAI Trading Suggestions With Accuracy Focus Released - beatles.ru

Aug 10, 2025

Aug 10, 2025

Can BioAtla Inc. Outperform Peers After Recent PullbackFundamental + Technical Hybrid Stock Tips Shared - beatles.ru

Aug 10, 2025

Aug 10, 2025

Does BioAtla Inc. stock have upside surprise potentialDaily Breakout Recap Watch - sisaissue.com

Aug 10, 2025

Aug 10, 2025

BioAtla, Inc. Reports Q2 2025 Financial Results and Clinical Progress - TipRanks

Aug 10, 2025

Aug 10, 2025

Head-To-Head Review: Alzamend Neuro (NASDAQ:ALZN) & BioAtla (NASDAQ:BCAB) - Defense World

Aug 10, 2025

Aug 09, 2025

Sector ETF performance correlation with BioAtla Inc.Free Alpha Driven Watchlist With Alerts - Newser

Aug 09, 2025

Aug 09, 2025

Comparing BioAtla Inc. in custom built stock radarsFree Swing Setup With Technical Confirmation - Newser

Aug 09, 2025

Aug 09, 2025

BioAtla's Strategic Position in Immuno-Oncology and Partnership-Driven Growth - AInvest

Aug 09, 2025

Aug 08, 2025

BioAtla August 2025 slides: promising clinical data amid financial headwinds By Investing.com - Investing.com Nigeria

Aug 08, 2025

Aug 08, 2025

Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts By Investing.com - Investing.com South Africa

Aug 08, 2025

Aug 08, 2025

Earnings call transcript: Bioatla Q2 2025 misses EPS forecasts - Investing.com India

Aug 08, 2025

Aug 08, 2025

BioAtla August 2025 slides: promising clinical data amid financial headwinds - Investing.com

Aug 08, 2025

Aug 08, 2025

BioAtla Inc Reports Q2 2025 EPS of -$0.32, Missing Estimates; Net Loss at $18.7 Million - AInvest

Aug 08, 2025

Aug 08, 2025

BioAtla faces Nasdaq delisting over share price rule - MSN

Aug 08, 2025

Aug 08, 2025

BioAtla Inc (BCAB) Q2 2025 Earnings Call Highlights: Promising Clinical Progress Amid Financial ... By GuruFocus - Investing.com Canada

Aug 08, 2025

Aug 07, 2025

Bioatla Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025

Aug 07, 2025

Transcript : BioAtla, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 07, 2025